
Aceclofenac (100mg) + Paracetamol (325mg) + Serratiopeptidase (15mg)
Active composition
+2 more active ingredients
Aceclofenac inhibits COX-1 and COX-2 enzymes, leading to decreased synthesis of prostaglandins, which are responsible for pain and inflammation.
Paracetamol works by inhibiting cyclooxygenase (COX) enzymes, leading to reduced synthesis of prostaglandins in the brain, which are responsible for pain and fever.
Serratiopeptidase acts as a proteolytic enzyme, breaking down fibrin and other proteins involved in inflammation, thereby reducing pain and swelling.
Medical applications
Zeroder-SP Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac 100 mg, Paracetamol 325 mg, and Serratiopeptidase 15 mg. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts potent anti-inflammatory and analgesic effects by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol provides effective analgesia and antipyretic action through central inhibition of prostaglandin synthesis, complementing the peripheral effects of Aceclofenac. Serratiopeptidase, a proteolytic enzyme, facilitates the reduction of inflammation and edema by breaking down inflammatory mediators and promoting tissue repair. This combination is indicated for the management of acute and chronic musculoskeletal pain, including osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and postoperative inflammation. Zeroder-SP offers symptomatic relief from pain, swelling, and stiffness, enhancing patient mobility and quality of life. It should be used with caution in patients with gastrointestinal ulcers, hepatic or renal impairment, and hypersensitivity to NSAIDs. Concomitant use with anticoagulants or corticosteroids requires medical supervision due to increased risk of adverse effects. Dosage and duration of therapy should be individualized based on clinical response and tolerability. Zeroder-SP Tablet should be administered under medical guidance to ensure safety and efficacy.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Safety information not available for this product. Please consult your doctor or pharmacist.
0 reviews for Zeroder-SP Tablet

Aceclofenac (100mg) + Paracetamol (325mg) + Serratiopeptidase (15mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+2 more active ingredients
Aceclofenac inhibits COX-1 and COX-2 enzymes, leading to decreased synthesis of prostaglandins, which are responsible for pain and inflammation.
Paracetamol works by inhibiting cyclooxygenase (COX) enzymes, leading to reduced synthesis of prostaglandins in the brain, which are responsible for pain and fever.
Serratiopeptidase acts as a proteolytic enzyme, breaking down fibrin and other proteins involved in inflammation, thereby reducing pain and swelling.
Medical applications
Zeroder-SP Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac 100 mg, Paracetamol 325 mg, and Serratiopeptidase 15 mg. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts potent anti-inflammatory and analgesic effects by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol provides effective analgesia and antipyretic action through central inhibition of prostaglandin synthesis, complementing the peripheral effects of Aceclofenac. Serratiopeptidase, a proteolytic enzyme, facilitates the reduction of inflammation and edema by breaking down inflammatory mediators and promoting tissue repair. This combination is indicated for the management of acute and chronic musculoskeletal pain, including osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and postoperative inflammation. Zeroder-SP offers symptomatic relief from pain, swelling, and stiffness, enhancing patient mobility and quality of life. It should be used with caution in patients with gastrointestinal ulcers, hepatic or renal impairment, and hypersensitivity to NSAIDs. Concomitant use with anticoagulants or corticosteroids requires medical supervision due to increased risk of adverse effects. Dosage and duration of therapy should be individualized based on clinical response and tolerability. Zeroder-SP Tablet should be administered under medical guidance to ensure safety and efficacy.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Safety information not available for this product. Please consult your doctor or pharmacist.
0 reviews for Zeroder-SP Tablet











